Curcumin

Curcumin is a lipophilic polyphenol (a diarylheptanoid, chemically 1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione, also called diferuloylmethane) isolated from the rhizome of Curcuma longa, or turmeric. It is the principal curcuminoid pigment of turmeric and is used commercially as the food colorant C.I. Natural Yellow 3 (E 100). Its structure — two phenolic feruloyl groups joined by an α,β-unsaturated β-diketone linker — underlies both its radical-scavenging chemistry and its keto–enol tautomerism, and it exists as a conjugated yellow-orange solid that is essentially insoluble in water but readily partitions into lipid environments such as phospholipid bilayers.

Biologically, curcumin behaves as a promiscuous, multi-target modulator rather than a single-receptor ligand. It suppresses inflammatory signaling through the NF-κB axis, including upstream TLR4/MyD88 activation, with downstream reduction of proinflammatory cytokines such as IL-6 and IL-1β, chemokines such as CXCL8, and enzymes including COX-2 and MMP-9. It also engages the Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)–Mtor pathway, affecting autophagy, proliferation, and apoptosis; modulates TGF-β signaling implicated in fibrosis; and activates Nrf2-driven antioxidant responses that lower reactive oxygen species and influence redox-dependent cell death programs such as ferroptosis. These overlapping activities account for the breadth of preclinical work on curcumin in oncology, metabolic disease, dermatologic and neurodegenerative conditions, and infection, where it is frequently studied alongside other polyphenols such as resveratrol, quercetin, and epigallocatechin gallate.

The dominant limitation of curcumin as a therapeutic is pharmacokinetic rather than pharmacodynamic: poor aqueous solubility, chemical instability at physiological pH, rapid intestinal and hepatic glucuronidation and sulfation, and low systemic exposure after oral dosing, compounded by limited penetration of the blood–brain barrier. Much contemporary research therefore concerns formulation — nanocrystals, liposomes and lipid-based carriers, polymeric and micellar systems using excipients such as chitosan, hyaluronic acid, or pectin, and Pickering emulsions stabilized by biopolymer particles — intended to raise bioavailability, direct tissue targeting, or enable stimulus-responsive release. The same optical and physicochemical properties that complicate its use as a drug also make it useful as an intrinsic fluorescence probe and as a chromogenic reporter in biosensing and photochemotherapy applications.